EMEA-001645-PIP01-14-M02

Key facts

Invented name
Zinplava
Active substance
bezlotoxumab
Therapeutic area
Infectious diseases
Decision number
P/0387/2017
PIP number
EMEA-001645-PIP01-14-M02
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of Clostridium difficile infection
Route(s) of administration
Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.
Tel. +31 412663179
E-mail: pip.information@merck.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating